HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Sub-New Stocks

417.379

+1.5930.38%

Number of Gainers:29

Number of Losers:19

Number of Flat:13

PE:- -

High:421.501

Open:415.787

Low:412.848

Close:415.787

Volume:126.83M

Turnover:4.29B

Market Cap:973.58B

Float Cap:865.19B

Loading ...

Keymed Biosciences FY2025; Kangyueda sales climb to CNY 315 million; revenue rises to CNY 716 million

Keymed Biosciences FY2025 revenue rises 67% to RMB716 million; operating loss widens to RMB521 million

Why Is Baidu Stock Sliding On Thursday?

Navigating the Profitability Adjustment Phase: How YUEXIU SERVICES Is Adapting to the Cycle

BRIEF-Acotec Scientific Holdings Posts FY Profit Attributable RMB119.2 Mln

Nayuki FY2025 net loss narrows 73.7% to RMB243 million; revenue falls 12% to RMB4.3 billion

HEARTCARE-B Reports Annual Profit of 83.3 Million Yuan with Hemorrhagic Stroke Revenue Surging 223%

Acotec Scientific proposes bylaw amendments; shares gain flexibility to be held as treasury stock

YUEXIU SERVICES Reports Robust 2025 Full-Year Results: Financial Strength and Diversified Growth Highlight Long-Term Value

Shanghai HeartCare Medical Technology FY2025 profit before tax jumps to RMB86 million; revenue rises 46.9% to RMB408 million

Bilibili-W Grants 949,000 Restricted Stock Units

Shanghai HeartCare Medical Technology FY Revenue RMB 408.3 Million

THOMSON REUTERS

Bilibili grants 949,277 RSUs under its 2018 share incentive plan; Class Z shares rise to HKD 182 on March 26, 2026

BRIEF-Yuexiu Services Group FY Revenue RMB 3,901.9 Million

BRIEF-Bairong Posts Full-Year Revenue Of RMB 1,901.15 Million

BRIEF-Medlive Technology Posts Full-Year Revenue Of RMB 642.2 Million

JPMorgan Chase & Co's Long Position in Bilibili Decreases to 15.32% on Mar 23 From 15.88% - HKEX

THOMSON REUTERS

JPMorgan & Chase Co's Short Position in Bilibili Decreases 9.37% on Mar 23 From 10.00% - HKEX

THOMSON REUTERS

Yuexiu Services Group FY2025 proposes a final dividend of HKD 0.037 per share; shareholders vote set for June 5, 2026

Li Auto's Struggle to Rediscover Its Winning Formula

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/BK1587/news?page=4"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK1587","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1587\",,,,,undefined,":{"symbol":"BK1587","market":"HK","secType":"PLATE","nameCN":"Sub-New Stocks","latestPrice":417.37915,"timestamp":1774598898612,"preClose":415.78662,"halted":0,"volume":126831300,"delay":0,"changeRate":0.00383,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Market Closed","change":1.592529,"latestTime":"03-27 16:00:00","open":415.78662,"high":421.50113,"low":412.84805,"amount":4290455674.5,"amplitude":0.020811,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1774834200000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1774575000000,1774584000000],[1774587600000,1774598400000]],"pbRate":1.790169,"peRate":16.823783,"turnoverRate":0.00266,"increases":28,"decrements":18,"flats":12,"marketCap":973577084210,"floatMarketCap":865187051038},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1587\",,,,,undefined,":{"symbol":"BK1587","high":421.50113,"amplitude":0.020811,"preClose":415.78662,"low":412.84805,"pbRate":"1.790169","latestPrice":417.37915,"volume":126831300,"delay":0,"open":415.78662,"prevYearClose":478.5753,"prevWeekClose":426.418,"prevMonthClose":430.579,"prevQuarterClose":478.575,"fiveDayClose":426.418,"twentyDayClose":430.579,"sixtyDayClose":483.604,"secType":"PLATE","market":"HK","turnoverRate":0.00266,"peRate":16.823783,"marketCap":973577084210,"floatMarketCap":865187051038,"timestamp":1774598898612,"nameCN":"Sub-New Stocks"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1587\",,,,undefined,":{"bkCode":"BK1587","up":29,"down":19,"flat":13},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1587\",pageSize:20,pageCount:4,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2622850032","title":"Keymed Biosciences FY2025; Kangyueda sales climb to CNY 315 million; revenue rises to CNY 716 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2622850032","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622850032?lang=en_us&edition=fundamental","pubTime":"2026-03-26 20:56","pubTimestamp":1774529771,"startTime":"0","endTime":"0","summary":"Keymed said its IL-4Rα antibody product Kangyueda has received NMPA approvals covering three indications, supporting broader commercial reach in China.The company reported CNY 315.0 million in sales revenue from Kangyueda, indicating early-scale commercialization traction.Keymed said all approved Kangyueda indications and both vial and prefilled autoinjector formats were added to China’s national reimbursement drug list starting January 2026, a move that could expand patient access and influence adoption.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Keymed Biosciences Inc. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on March 26, 20","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260326:nNDL29GhMM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","02162","BK1587","BK1583","BK1161"],"gpt_icon":0},{"id":"2622850740","title":"Keymed Biosciences FY2025 revenue rises 67% to RMB716 million; operating loss widens to RMB521 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2622850740","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622850740?lang=en_us&edition=fundamental","pubTime":"2026-03-26 20:56","pubTimestamp":1774529767,"startTime":"0","endTime":"0","summary":"Keymed published an annual results announcement for the year ended Dec. 31, 2025, reporting revenue of RMB716.3 million, up 67% year over year.Cost of sales was RMB88.0 million, while gross profit was RMB628.3 million, up 51%.Loss for the year was RMB522.6 million; adjusted loss for the year was RMB494.8 million.Cash and cash equivalents, time deposits, restricted cash and bank wealth management products totaled RMB2.0 billion, down 9%.Management said sales revenue from Kangyueda was about RMB315 million, up more than 8x, and attributed higher selling and distribution expenses of RMB322.0 million to increased Kangyueda sales.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Keymed Biosciences Inc. published the original content used to g","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260326:nNDLbR3PQY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","02162","BK1583","BK1161","BK1587"],"gpt_icon":0},{"id":"2622857658","title":"Why Is Baidu Stock Sliding On Thursday?","url":"https://stock-news.laohu8.com/highlight/detail?id=2622857658","media":"Benzinga","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622857658?lang=en_us&edition=fundamental","pubTime":"2026-03-26 20:10","pubTimestamp":1774527000,"startTime":"0","endTime":"0","summary":"Baidu Inc  shares are retreating during Thursday's premarket session.The move follows a broader sell-off in Chinese technology equities. Geopolitical uncertainty in the Middle East is driving the current market decline.The U.S.-Iran conflict entered its 27th day on Thursday. President Donald Trump warned Iran to accept military defeat.White House Press Secretary Karoline Leavitt stated Trump is prepared to \"unleash hell.\". This rhetoric has pushed investors toward safe-haven assets. Consequently, high-growth tech sectors are facing significant selling pressure. Major Chinese indices mirrored this weakness.The Shanghai Composite Index fell 1.09% on Thursday. Meanwhile, Hong Kong's Hang Seng Index dropped 1.89%.Technology stocks led these losses across Asian exchanges. Traders remain concerned about volatile oil prices and global inflation. Japan has already started releasing state oil reserves to temper price surges.\"We do not plan on any negotiations,\" Araghchi told state TV. Ongoing m","market":"hk","thumbnail":"https://cdn.benzinga.com/files/images/story/2026/03/26/The-Baidu-Trade.jpeg?optimize=medium&dpr=2&auto=webp&width=630","type":0,"news_type":0,"thumbnails":["https://cdn.benzinga.com/files/images/story/2026/03/26/The-Baidu-Trade.jpeg?optimize=medium&dpr=2&auto=webp&width=630"],"rights":{"source":"benzinga_hot_news","url":"https://www.benzinga.com/trading-ideas/movers/26/03/51478746/why-is-baidu-stock-sliding-on-thursday","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/trading-ideas/movers/26/03/51478746/why-is-baidu-stock-sliding-on-thursday","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_hot_news","symbols":["LU1023057109.AUD","LU2778985437.USD","LU0417516902.SGD","LU1048596156.SGD","LU0762541174.USD","BK4077","BK4614","LU0229945570.USD","LU0287142896.SGD","HK0000306685.HKD","LU0164865239.USD","LU0456827905.SGD","BK4535","BK4504","LU0228367735.SGD","LU0039217434.USD","LU0630378429.USD","BK1587","LU0359202008.SGD","HK0000320223.HKD","BK4531","BK4585","LU0051755006.USD","LU0348825331.USD","BIDU","BK4579","LU0531971595.HKD","LU0856984785.SGD","LU0708995583.HKD","LU0359201612.USD","LU1831875114.USD","HK0000306701.USD","LU0043850808.USD","LU0762540952.USD","LU1188198961.HKD","LU0072462343.USD","LU0197773673.USD","LU0052750758.USD","LU0307460666.USD","LU0823426480.USD","BK4587","LU1048588211.SGD","LU0315179316.USD","BK1615","LU1115378108.SGD","LU0630378692.HKD","SG9999014674.SGD","LU0320764599.SGD","LU2039709279.SGD","LU0417516738.SGD","89888","LU0149721374.USD","LU2476274308.USD","LU0244354667.USD","BK4602","BK4217","BK4548","BK1588","IE0034224299.USD","SG9999002463.SGD","BK4526","LU0821914370.USD","LU0163747925.USD","LU0543330566.HKD","LU0326950275.SGD","BK4552","LU0640798160.USD","BK4574","LU1481107354.HKD","KBDU","BK4588","BK1609","LU0819121731.USD","LU0173614495.USD","HK0000320264.USD","LU0463099449.HKD","LU0871576103.HKD","BIDG","LU0831093199.SGD","SG9999002828.SGD","BK1575","BK4543","09888","LU0588546209.SGD","IE00B0JY6N72.USD","LU0197773160.USD","BK4514","BK1095","LU0348735423.USD","LU0762542818.HKD","LU1328615791.USD","LU0164880469.USD","BK4612","LU0823426308.USD"],"gpt_icon":1},{"id":"1158166638","title":"Navigating the Profitability Adjustment Phase: How YUEXIU SERVICES Is Adapting to the Cycle","url":"https://stock-news.laohu8.com/highlight/detail?id=1158166638","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1158166638?lang=en_us&edition=fundamental","pubTime":"2026-03-26 20:07","pubTimestamp":1774526826,"startTime":"0","endTime":"0","summary":"As the real estate sector enters a period of deep adjustment, the property management industry has moved beyond its previous phase of rapid expansion and fully entered a new stage characterized by...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1587","BK1542","06626","BK1229","BK1258"],"gpt_icon":0},{"id":"2622740854","title":"BRIEF-Acotec Scientific Holdings Posts FY Profit Attributable RMB119.2 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2622740854","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622740854?lang=en_us&edition=fundamental","pubTime":"2026-03-26 19:43","pubTimestamp":1774525419,"startTime":"0","endTime":"0","summary":"BRIEF-Acotec Scientific Holdings Posts FY Profit Attributable RMB119.2 MlnMarch 26 (Reuters) - Acotec Scientific Holdings Ltd 6669.HK:FY PROFIT ATTRIBUTABLE RMB119.2 MILLIONFY REVENUE RMB 644.6 MILLIONFurther company coverage: 6669.HK ((Reuters.Briefs@thomsonreuters.com;))","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260326:nFWN40E0HC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1100","BK1574","06669","BK1587"],"gpt_icon":0},{"id":"2622854760","title":"Nayuki FY2025 net loss narrows 73.7% to RMB243 million; revenue falls 12% to RMB4.3 billion","url":"https://stock-news.laohu8.com/highlight/detail?id=2622854760","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622854760?lang=en_us&edition=fundamental","pubTime":"2026-03-26 19:42","pubTimestamp":1774525336,"startTime":"0","endTime":"0","summary":"Nayuki published an annual results announcement, reporting revenue of RMB4.33 billion, down 12.0%.Net loss was RMB243.46 million, while adjusted net loss was RMB240.51 million, narrowing 73.8%.Net cash generated from operating activities rose 35.7% to RMB273.60 million.Store count totaled 1,646 teahouses , down from the prior year as the company implemented store optimization measures including closures, renovations and store-type adjustments.Management said it plans to complete optimization of remaining underperforming stores by 2026 and ended the year with cash and deposits of RMB2.66 billion.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Nayuki Holdings Ltd. published the original content used to generate this news brief via IIS, t","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260326:nNDL1jtXxp:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1616","BK1587","BK1233","02150"],"gpt_icon":0},{"id":"1198003840","title":"HEARTCARE-B Reports Annual Profit of 83.3 Million Yuan with Hemorrhagic Stroke Revenue Surging 223%","url":"https://stock-news.laohu8.com/highlight/detail?id=1198003840","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1198003840?lang=en_us&edition=fundamental","pubTime":"2026-03-26 18:58","pubTimestamp":1774522738,"startTime":"0","endTime":"0","summary":"HEARTCARE-B (06609) announced its financial results for the year ended December 31, 2025. The group recorded revenue of 408 million yuan, representing a year-on-year increase of 46.9%. Gross profit...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1587","BK1574","BK1100","06609"],"gpt_icon":0},{"id":"2622101859","title":"Acotec Scientific proposes bylaw amendments; shares gain flexibility to be held as treasury stock","url":"https://stock-news.laohu8.com/highlight/detail?id=2622101859","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622101859?lang=en_us&edition=fundamental","pubTime":"2026-03-26 18:52","pubTimestamp":1774522378,"startTime":"0","endTime":"0","summary":"Acotec Scientific proposed amendments to its memorandum and articles of association to align with shareholder protection standards in the Hong Kong listing rules.The changes would allow shareholders to attend general meetings virtually and vote electronically.The amendments would also permit the company to hold repurchased shares as treasury shares.Approval will be sought through a special resolution at the company’s next annual general meeting.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Acotec Scientific Holdings Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on March 26, 2026, and is solely responsible for the information con","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260326:nNDL2fRcmD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","LU2362540622.SGD","SGXZ57979304.SGD","LU0267386448.USD","LU0353189763.USD","BSX","LU0432979614.USD","LU1791710400.SGD","SG9999001176.USD","LU1061106388.HKD","BK4588","IE00B2B36J28.USD","LU1153585028.USD","LU0528227936.USD","LU0353189680.USD","LU1718418525.SGD","IE0009355771.USD","LU1291159041.SGD","SG9999001176.SGD","LU2506951958.HKD","LU0882574055.USD","BK1587","LU0823417737.USD","LU2491050154.USD","06669","LU2506952097.USD","LU0345769631.USD","LU1057294990.SGD","LU2244417387.USD","LU2324357040.USD","IE00BJT1NW94.SGD","LU1548497426.USD","LU0823417653.USD","LU0823416689.USD","LU1366192091.USD","LU2357305700.SGD","BK4082","BK4504","SG9999013999.USD","LU2242649171.HKD","LU1989772923.USD","BK4581","LU2506952170.USD","LU1983299246.USD","IE00BFTCPJ56.SGD","LU2491049909.HKD","BK1574","BK1100","IE00BJJMRZ35.SGD","LU2362541273.HKD"],"gpt_icon":0},{"id":"1129603301","title":"YUEXIU SERVICES Reports Robust 2025 Full-Year Results: Financial Strength and Diversified Growth Highlight Long-Term Value","url":"https://stock-news.laohu8.com/highlight/detail?id=1129603301","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1129603301?lang=en_us&edition=fundamental","pubTime":"2026-03-26 18:51","pubTimestamp":1774522271,"startTime":"0","endTime":"0","summary":"On March 26, YUEXIU SERVICES (06626) disclosed its full-year 2025 results. Amidst a complex environment of industry-wide adjustments and intense competition in the property management sector, the...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1587","BK1258","BK1229","BK1542","06626"],"gpt_icon":0},{"id":"2622593988","title":"Shanghai HeartCare Medical Technology FY2025 profit before tax jumps to RMB86 million; revenue rises 46.9% to RMB408 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2622593988","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622593988?lang=en_us&edition=fundamental","pubTime":"2026-03-26 18:41","pubTimestamp":1774521700,"startTime":"0","endTime":"0","summary":"HeartCare published an annual results announcement for the year ended Dec. 31, 2025.Revenue rose 46.9% to RMB 408.3 million, and gross profit increased 59.3% to RMB 289.5 million.Gross margin was 70.9%, up 5.5 percentage points, driven by a higher revenue share of higher-margin innovative products and cost reductions including production process improvements and supply chain optimization.Profit before tax was RMB 86.4 million, and net profit attributable to owners of the parent was RMB 83.3 million.Management said growth was supported by ischemic stroke revenue up 31.8%, hemorrhagic stroke revenue more than tripled, and interventional access revenue exceeding RMB 100.0 million, while overseas market revenue more than doubled on faster product registration and promotion.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purp","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260326:nNDL9K5rFt:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","06609","BK1587","BK1100"],"gpt_icon":0},{"id":"1100334026","title":"Bilibili-W Grants 949,000 Restricted Stock Units","url":"https://stock-news.laohu8.com/highlight/detail?id=1100334026","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1100334026?lang=en_us&edition=fundamental","pubTime":"2026-03-26 18:41","pubTimestamp":1774521660,"startTime":"0","endTime":"0","summary":"Bilibili-W (09626) announced that on March 26, 2026, the company issued a total of 949,000 restricted stock units to 102 employees within the group under the Second Amended and Restated 2018 Share...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4504","BK1618","BK1587","BK4548","BK1588","SG9999003461.SGD","BK4554","BK4566","BK4503","BK4509","LU2097828631.EUR","LU2097828557.USD","BK4505","IE0034224299.USD","BK4085","BK4526","BK4531","BK4577","BK4588","BK4077","BK1104","SG9999001093.SGD","BK1608","LU2097828714.EUR","BILI","BK1095","SG9999001051.SGD","SG9999001069.SGD","09626","BK4563","SG9999006597.SGD","BK4510","BK4513","BK4585","BK1615","LU2097828805.USD","BK1575","LU2097828474.EUR"],"gpt_icon":1},{"id":"2622859873","title":"Shanghai HeartCare Medical Technology FY Revenue RMB 408.3 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2622859873","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622859873?lang=en_us&edition=fundamental","pubTime":"2026-03-26 18:40","pubTimestamp":1774521632,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260326:nPLX99F237:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1587","BK1574","06609","BK1100"],"gpt_icon":0},{"id":"2622856057","title":"Bilibili grants 949,277 RSUs under its 2018 share incentive plan; Class Z shares rise to HKD 182 on March 26, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2622856057","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622856057?lang=en_us&edition=fundamental","pubTime":"2026-03-26 18:35","pubTimestamp":1774521345,"startTime":"0","endTime":"0","summary":"Bilibili granted 949,277 restricted share units to 102 employees under its Second Amended and Restated 2018 Share Incentive Plan.The awards have a nil purchase price and represent about 0.23% of the company’s total shares in issue on a one share one vote basis.Class Z ordinary shares were priced at HKD 182.3 per share on the grant date.The RSUs are scheduled to vest between March 26, 2027 and March 26, 2032.The plan’s scheme limit is 41,413,503 Class Z ordinary shares, with 27,755,082 shares remaining available for further awards after the grant.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Bilibili Inc. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong S","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260326:nNDL2NYB1Q:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1608","BK4503","BK4509","BK1587","BK4585","SG9999001069.SGD","BK4085","09626","BK1575","BK4510","LU2097828557.USD","BILI","BK4588","SG9999006597.SGD","BK4566","BK4513","BK1104","BK4554","BK4504","BK1588","IE0034224299.USD","LU2097828805.USD","BK4563","BK4548","LU2097828714.EUR","SG9999003461.SGD","BK4077","BK1095","BK4531","BK1615","LU2097828631.EUR","BK1618","BK4505","BK4577","BK4526","LU2097828474.EUR","SG9999001051.SGD","SG9999001093.SGD"],"gpt_icon":1},{"id":"2622856791","title":"BRIEF-Yuexiu Services Group FY Revenue RMB 3,901.9 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2622856791","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622856791?lang=en_us&edition=fundamental","pubTime":"2026-03-26 18:34","pubTimestamp":1774521297,"startTime":"0","endTime":"0","summary":"BRIEF-Yuexiu Services Group FY Revenue RMB 3,901.9 MillionMarch 26 (Reuters) - Yuexiu Services 6626.HK:FY REVENUE RMB 3,901.9 MILLIONFY PROFIT ATTRIBUTABLE RMB273.7 MILLIONTO DECLARE FINAL DIVIDEND OF HKD0.037 PER SHAREFurther company coverage: 6626.HK ((Reuters.Briefs@thomsonreuters.com;))","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260326:nPLX9267B8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1229","06626","BK1542","BK1258","BK1587"],"gpt_icon":0},{"id":"2622856100","title":"BRIEF-Bairong Posts Full-Year Revenue Of RMB 1,901.15 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2622856100","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622856100?lang=en_us&edition=fundamental","pubTime":"2026-03-26 18:28","pubTimestamp":1774520913,"startTime":"0","endTime":"0","summary":"BRIEF-Bairong Posts Full-Year Revenue Of RMB 1,901.15 MillionMarch 26 (Reuters) - Bairong Inc 6608.HK:FY REVENUE RMB 1,901.15 MILLIONFY PROFIT ATTRIBUTABLE RMB66.9 MILLIONFurther company coverage: 6608.HK ((Reuters.Briefs@thomsonreuters.com;))","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260326:nPLXA1B2B3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1575","BK1583","06608","BK1587","BK1131"],"gpt_icon":0},{"id":"2622285610","title":"BRIEF-Medlive Technology Posts Full-Year Revenue Of RMB 642.2 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2622285610","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622285610?lang=en_us&edition=fundamental","pubTime":"2026-03-26 18:28","pubTimestamp":1774520891,"startTime":"0","endTime":"0","summary":"BRIEF-Medlive Technology Posts Full-Year Revenue Of RMB 642.2 MillionMarch 26  - Medlive Technology Co Ltd 2192.HK:FY REVENUE RMB 642.2 MILLIONFINAL DIVIDEND OF RMB0.1435 PER SHAREFY PROFIT ATTRIBUTABLE RMB334.3 MILLIONFurther company coverage: 2192.HK ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260326:nPLX97B8A8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1189","LU1046422090.SGD","BK1587","02192","LU1235295612.USD","LU0049112450.USD"],"gpt_icon":0},{"id":"2622785501","title":"JPMorgan Chase & Co's Long Position in Bilibili  Decreases to 15.32% on Mar 23 From 15.88% - HKEX","url":"https://stock-news.laohu8.com/highlight/detail?id=2622785501","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622785501?lang=en_us&edition=fundamental","pubTime":"2026-03-26 18:10","pubTimestamp":1774519825,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260326:nFWN40E0CP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1608","JPM","BK1587","SG9999001069.SGD","09626","BK1575","LU2097828557.USD","BILI","SG9999006597.SGD","BK1104","BK1588","IE0034224299.USD","LU2097828805.USD","LU2097828714.EUR","SG9999003461.SGD","BK1095","BK1615","LU2097828631.EUR","BK1618","LU2097828474.EUR","SG9999001051.SGD","SG9999001093.SGD"],"gpt_icon":0},{"id":"2622563678","title":"JPMorgan & Chase Co's Short Position in Bilibili  Decreases 9.37% on Mar 23 From 10.00% - HKEX","url":"https://stock-news.laohu8.com/highlight/detail?id=2622563678","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622563678?lang=en_us&edition=fundamental","pubTime":"2026-03-26 18:10","pubTimestamp":1774519825,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260326:nFWN40E0CP:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1608","LU2097828631.EUR","IE0034224299.USD","BK1618","BK1104","BILI","LU2097828557.USD","BK1575","BK1615","LU2097828714.EUR","SG9999003461.SGD","SG9999001069.SGD","09626","LU2097828474.EUR","BK1588","BK1587","LU2097828805.USD","BK1095","SG9999001093.SGD","SG9999001051.SGD","SG9999006597.SGD"],"gpt_icon":0},{"id":"2622855895","title":"Yuexiu Services Group FY2025 proposes a final dividend of HKD 0.037 per share; shareholders vote set for June 5, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2622855895","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622855895?lang=en_us&edition=fundamental","pubTime":"2026-03-26 17:51","pubTimestamp":1774518683,"startTime":"0","endTime":"0","summary":"Shareholder approval is scheduled for June 5, 2026.The shares are expected to trade ex-dividend on June 11, 2026.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Yuexiu Services Group Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on March 26, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260326:nNDL3Qf5rM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1542","LU2279858448.HKD","BK1587","00123","BK1229","BK1258","BK1555","LU1171460220.USD","06626","BK1240"],"gpt_icon":0},{"id":"1167882825","title":"Li Auto's Struggle to Rediscover Its Winning Formula","url":"https://stock-news.laohu8.com/highlight/detail?id=1167882825","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1167882825?lang=en_us&edition=fundamental","pubTime":"2026-03-26 17:24","pubTimestamp":1774517061,"startTime":"0","endTime":"0","summary":"Every gift from fate comes with a hidden price. This summary of Marie Antoinette's dramatic life, by Stefan Zweig, aptly applies to China's \"Wei Xiao Li\" trio—especially to Li Auto today. The year...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09866","BK1587","EVS.SI","BK4531","NIO.SI","BK4099","BK4563","LU1720050803.USD","BK4588","BK4503","BK4585","AIYY","BK4534","LI","BK4509","BK4504","BK4548","BK4587","CHAT","NIOG","02015","BK1588","BK4528","LU0320764599.SGD","LU0052750758.USD","BK4551","AGIX","AI","BK1575","LU0708995583.HKD","BK4555","BK4526","AIPO","BK4023","BK1119","LU1794554557.SGD","BK4505","BK4532","BK4543","BK4574","BK6125","BK4581","BK1539"],"gpt_icon":1}],"pageSize":20,"totalPage":18,"pageCount":4,"totalSize":350,"code":"91000000","status":"200"}]}}